BDRX: 110% | Biodexa Pharmaceuticals Presents Phase 2 Clinical Trial Results Of Its Newly-Licensed eRapa In Familial Adenomatous Polyposis Scheduled For Presentation At The 2024 Digestive Disease Week Annual Meeting; Reports Overall 83% Non-Progression Rate At 6 Months

MMAT: 95% | Meta Materials shares are trading higher after the company announced that lawyers concluded that it has meritorious claims for market manipulation against several parties.

SPT: -11% | Sprout Social shares are trading lower after the company said there is no process in place to sell or take the Company private.